CD40 Pathway Activation Status Predicts Response to CD40 Targeted Therapy in Diffuse Large b-Cell Lymphoma. 51st Annual Meeting and Exposition of the American-Society-of-Hematology Dornan, D., Burington, B., Yue, P., Shi, X., Advani, R., Yu, N., Lau, J. T., Yu, S., de Vos, S., Ansell, S. M., Forero-Torres, A., Modrusan, Z., Koeppen, H., Yang, T., Du, C., Elkins, K., Polson, A. G., Offringa, R., Whiting, N., Ebens, A. J. AMER SOC HEMATOLOGY. 2009: 1065–65

View details for Web of Science ID 000272725803276